Significantly lower CYP2D6 metabolism measured as the O/N ‐desmethylvenlafaxine metabolic ratio in carriers of CYP2D6*41 versus CYP2D6*9 or CYP2D6*10 – A study on therapeutic drug monitoring data from 1,003 genotyped Scandinavian patients

British Journal of Clinical Pharmacology,Volume 0, Issue ja, -Not available-.

Source: British Journal of Clinical Pharmacology - October 12, 2018 Category: Drugs & Pharmacology Authors: Tore Haslemo, Erik Eliasson, Marin M. Juki ć, Magnus Ingelman‐Sundberg, Espen Molden Source Type: research